G
Garret A. FitzGerald
Researcher at University of Pennsylvania
Publications - 573
Citations - 64984
Garret A. FitzGerald is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Prostacyclin & Thromboxane. The author has an hindex of 127, co-authored 547 publications receiving 60448 citations. Previous affiliations of Garret A. FitzGerald include French Institute of Health and Medical Research & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
A rattle bag of science and the art of translation.
TL;DR: Science Translational Medicine’s new Co–Chief Scientific Advisors define translational science and articulate their vision for the journal.
Journal ArticleDOI
Isoprostanes: Chemistry and Biological Significance
Joshua Rokach,Subhash P. Khanapure,Seongwoo Hwang,Mustafa Adiyaman,Zaher Elmir,John A. Lawson,Garret A. FitzGerald +6 more
Patent
Compositions and methods for regulating circadian rhythyms
TL;DR: In this article, a method of effecting a change in the core circadian clock by modulating retinoid nuclear receptors was proposed, which was shown to be effective in the case of the human brain.
Journal ArticleDOI
Non-steroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal Hematodiaphyseal Dysplasia.
Timothy J. Brown,Neil A Barrett,Hu Meng,Emanuela Ricciotti,Ciara McDonnell,Andrew Dancis,Julianne N. Qualtieri,Garret A. FitzGerald,Melanie Cotter,Daria V. Babushok +9 more
TL;DR: In this article , a targeted therapeutic approach for Ghosal hematodiaphyseal dysplasia, an autosomal recessive disease characterized by severe normocytic anemia and bone abnormalities due to loss-of-function mutations in Thromboxane A Synthase 1 (TBXAS1), was described.
Journal ArticleDOI
Battle for supremacy: nucleic acid interactions between viruses and cells.
TL;DR: It is considered how variation in the epigenome may contribute to heterogeneity in the response to SARS-CoV-2 and may identify a precision medicine approach to treatment.